z-logo
open-access-imgOpen Access
Human T‐cell leukemia virus type 1 Tax protein interacts with and mislocalizes the PDZ domain protein MAGI ‐1
Author(s) -
Makokha Grace Naswa,
Takahashi Masahiko,
Higuchi Masaya,
Saito Suguru,
Tanaka Yuetsu,
Fujii Masahiro
Publication year - 2013
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/cas.12087
Subject(s) - pdz domain , biology , hek 293 cells , human t lymphotropic virus 1 , microbiology and biotechnology , cell culture , t cell leukemia , cell , virology , virus , biochemistry , genetics
Human T‐cell leukemia virus type 1 ( HTLV ‐1) is the etiological agent of adult T‐cell leukemia ( ATL ). HTLV‐1 encodes the oncoprotein Tax1, which is essential for immortalization of human T ‐cells and persistent HTLV ‐1 infection in vivo . Tax1 has a PDZ binding motif (PBM) at its C‐terminus. This motif is crucial for the transforming activity of Tax1 to a T‐cell line and persistent HTLV‐1 infection. Tax1 through the PBM interacts with PDZ domain proteins such as Dlg1 and Scribble, but it has not been determined yet, which cellular PDZ proteins mediate the functions of Tax1 PBM. Here we demonstrate that Tax1 interacts with the PDZ domain protein MAGI‐1 in a PBM‐dependent manner, and the interaction mislocalizes MAGI‐1 from the detergent‐soluble to the detergent‐insoluble cellular fraction in 293T cells and in HTLV‐1‐infected T‐cells. In addition, Tax1‐transformation of a T‐cell line from interleukin (IL)‐2‐dependent to IL‐2‐independent growth selects cells with irreversibly reduced expression of MAGI‐1 at mRNA level. These findings imply that Tax1, like other viral oncoproteins, targets MAGI‐1 as a mechanism to suppress its anti‐tumor functions in HTLV‐1‐infected cells to contribute to the transforming activity of T‐cells and persistent HTLV‐1 infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here